Ashland Inc.

Ashland Inc. (ASH) Stock Analysis

$72.650

+1.918 (+2.64%)At close

Loading chart…
High
73.060
Open
71.200
VWAP
72.11
Volume
388.86K
Mkt Cap
4.73B
Low
70.625
Amount
28.04M
EV/EBITDA, TTM
10.37

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.

AI analysis of Ashland Inc. (ASH)

Buy

Ashland Inc is a good buy right now, trading at $70.57, with a forward P/E of 15.748 indicating reasonable valuation compared to its growth prospects. The stock has shown a 1-year change of +45.96%, reflecting strong recovery and growth in sales, which increased by 7% to $497 million in Q3. However, the main risk is the negative net income margin of -3.63% in Q1 2026, which highlights ongoing profitability challenges.

Analyst Ratings (11)

-8.23% Downside
Buy
8 Buy
3 Hold
0 Sell
Current: 72.65
Low
53.00
Average
66.67
High
73.00

UBS

2026-10-05

Price Target

$80

Buy

Wolfe Research

2026-08-10

Price Target

$83

Outperform

Morgan Stanley

2026-08-06

Price Target

$78

Equal Weight

Deutsche Bank

2026-07-31

Price Target

$85

Buy

JPMorgan

2026-07-30

Price Target

$80

Overweight

Valuation Metrics

The current forward P/E ratio for Ashland Inc. (ASH) is 15.75, compared to its 5-year average forward P/E of 16.61.

Forward P/E

Fair
5Y Average P/E
16.61
Current P/E
15.75
Overvalued
19.82
Undervalued
13.40

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.33
Current EV/EBITDA
10.37
Overvalued
14.85
Undervalued
3.81

Forward P/S

Fair
5Y Average P/S
1.92
Current P/S
1.68
Overvalued
2.35
Undervalued
1.48

Alphio AI Price Scenarios for ASH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ASH

$54.72

Scenario price

B

Base

Base · 50%ASH

$47.77

Scenario price

B

Bear

Bear · 25%ASH

$45.19

Scenario price

Whales holding ASH

S

Standard Investments LLC

+ HoldingASH

+17.92%

3M Return

H

Hantz Financial Services, Inc.

+ HoldingASH

+7.94%

3M Return

N

Newport Trust Company

+ HoldingASH

-2.07%

3M Return

A

Ancora Advisors LLC

+ HoldingASH

-5.40%

3M Return

C

Cramer Rosenthal McGlynn LLC

+ HoldingASH

-5.77%

3M Return

F

Frontier Capital Management

+ HoldingASH

-9.80%

3M Return

Events Timeline

2026-10-06 (ET)

16:00:00

Ashland's Sales Process Advances with Interest from Several Private Equity Firms

2026-09-22 (ET)

07:30:00

Ashland Launches New Agricultural Dispersant Globally

2026-09-15 (ET)

16:00:00

Ashland Running Sales Process, Private Equity Firms Interested

2026-08-07 (ET)

16:30:00

Ashland Explores Potential Sale, Shares Up 5%

16:00:00

Ashland Exploring Sale After Takeover Interest, Bloomberg Reports

News

ASH FAQ — answered by Alphio AI

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone. It operates in the Basic Materials sector (WHOLESALE-CHEMICALS & ALLIED PRODUCTS industry).

Ashland Inc is a good buy right now, trading at $70.57, with a forward P/E of 15.748 indicating reasonable valuation compared to its growth prospects. The stock has shown a 1-year change of +45.96%, reflecting strong recovery and growth in sales, which increased by 7% to $497 million in Q3. However, the main risk is the negative net income margin of -3.63% in Q1 2026, which highlights ongoing profitability challenges.

11 analysts cover ASH: 8 rate it Buy, 3 Hold and 0 Sell. The average price target is 66.67.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started